3,4-dihydroxyphenylacetic acid and 5-s-cysteinyldopamine

3,4-dihydroxyphenylacetic acid has been researched along with 5-s-cysteinyldopamine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (57.14)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Carlsson, A; Fornstedt, B3
Carlsson, A; Fornstedt, B; Pileblad, E1
Halliwell, B; Jenner, P; Spencer, JP; Whiteman, M1
Goldstein, DS; Holmes, C; Jinsmaa, Y; Kopin, IJ; Sharabi, Y; Sullivan, P1
Bermejo, MK; Dunn, AR; Fu, R; Goldstein, DS; Gregersen, E; Jensen, PH; Masoud, ST; Miller, GW; Nazari, R; Ramsey, A; Salahpour, A; Sullivan, P; Urs, NM; Vecchio, LM1

Other Studies

7 other study(ies) available for 3,4-dihydroxyphenylacetic acid and 5-s-cysteinyldopamine

ArticleYear
Effects of inhibition of monoamine oxidase on the levels of 5-S-cysteinyl adducts of catechols in dopaminergic regions of the brain of the guinea pig.
    Neuropharmacology, 1991, Volume: 30, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Catechols; Chromatography, High Pressure Liquid; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Female; Guinea Pigs; Limbic System; Oxidation-Reduction; Pargyline; Reserpine; Time Factors

1991
Vitamin C deficiency facilitates 5-S-cysteinyldopamine formation in guinea pig striatum.
    Journal of neurochemistry, 1991, Volume: 56, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Ascorbic Acid; Ascorbic Acid Deficiency; Cerebellum; Corpus Striatum; Dopamine; Female; Guinea Pigs; Limbic System; Norepinephrine

1991
Catechol metabolites in the cerebrospinal fluid as possible markers in the early diagnosis of Parkinson's disease.
    Neurology, 1991, Volume: 41, Issue:5 Suppl 2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Catechols; Dopamine; Guinea Pigs; Humans; Oxidation-Reduction; Parkinson Disease; Time Factors

1991
In vivo autoxidation of dopamine in guinea pig striatum increases with age.
    Journal of neurochemistry, 1990, Volume: 55, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aging; Animals; Brain; Cerebral Cortex; Corpus Striatum; Cysteinyldopa; Dopamine; Female; Glutathione; Guinea Pigs; Oxidation-Reduction

1990
5-s-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons.
    Journal of neurochemistry, 2002, Volume: 81, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caspase 3; Caspases; Catecholamines; Cell Survival; Cells, Cultured; Cysteine; Cysteinyldopa; DNA; Dopamine; Dose-Response Relationship, Drug; Enzyme Activation; Intracellular Fluid; Levodopa; Methamphetamine; Neurons; Purines; Pyrimidines; Rats; Reactive Oxygen Species

2002
Elevated cerebrospinal fluid ratios of cysteinyl-dopamine/3,4-dihydroxyphenylacetic acid in parkinsonian synucleinopathies.
    Parkinsonism & related disorders, 2016, Volume: 31

    Topics: 3,4-Dihydroxyphenylacetic Acid; Aged; Animals; Catechols; Dihydroxyphenylalanine; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; PC12 Cells; Putamen; Rats

2016
Enhanced tyrosine hydroxylase activity induces oxidative stress, causes accumulation of autotoxic catecholamine metabolites, and augments amphetamine effects in vivo.
    Journal of neurochemistry, 2021, Volume: 158, Issue:4

    Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Catecholamines; Central Nervous System Stimulants; Dopamine; Female; Gene Dosage; Glutathione; Humans; Hydrogen Peroxide; Male; Mice; Mice, Transgenic; Neurons; Oxidative Stress; Tyrosine 3-Monooxygenase

2021